Farms.com Home   Farm Equipment News

The New John Deere 644K Hybrid Loader Breaks Into Construction

John Deere has announced the release of the 644K Powerllel™ diesel-electric hybrid front loader which will reduce fuel consumption by up to 25% and cut down on job site noise. This Deere front loader is designed with powerful digging forces along with a parallel fork-lift design to ensure heavy loads work with, and not against, the boom.

According to Deere’s product description, the 644K loader features a PowerShift™ transmission, NeverGrease™ joints, and an IT4-certified PowerTech™ 6.8-liter diesel engine with 229 horsepower. The hybrid engine uses an electric drive system which is comprised of four components: an electric motor, generator, inverter, and brake resistor. Deere reported that the electric motor can also be converted to a generator to recycle energy back into the system to save fuel.

John Chesterman, John Deere’s product marketing manager of 4x4 loaders, said “…the constant engine speed helps extend engine life and reduce fuel consumption while the electric motor cuts down on noise on the job.” During the World of Concrete show, Chesterman stated that one of the most innovative features of the 644K is the simplified PowerShift™ countershaft-style transmission that has three speeds and a water-cooled brake resistor.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.